Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bilateral breast cancer.

A A Fracchia1, P I Borgen

  • 1Breast Service, Memorial Sloan-Kettering Cancer Center, New York, New York.

Seminars in Surgical Oncology
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Managing contralateral breast cancer remains challenging, with options ranging from surveillance to biopsy. Identifying risk factors and prevention strategies is crucial for improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of sentinel lymph node biopsy in Paget's disease of the breast.

Annals of surgical oncology·2007
Same author

Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases.

Journal of medical genetics·2005
Same author

Sentinel lymph node biopsy: an American perspective.

Breast (Edinburgh, Scotland)·2004
Same author

Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer.

Annals of surgical oncology·2003
Same author

A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2002
Same author

A prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location [corrected].

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2002
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Area of Science:

  • Oncology
  • Breast Cancer Research

Background:

  • Bilateral breast cancer occurs in 7-20% of operable primary cases, often metachronously.
  • Management consensus for contralateral breast cancer is lacking, impacting prognosis assessment.

Purpose of the Study:

  • To explore the complexities and current management strategies for contralateral breast cancer.
  • To identify factors influencing the risk of developing a second primary breast cancer.

Main Methods:

  • Review of existing literature on bilateral breast cancer incidence and management.
  • Analysis of factors contributing to contralateral breast cancer risk.

Main Results:

  • Contralateral breast cancer risk is influenced by patient age, in situ disease, lobular histology, multicentricity, irradiation, and family history.

Related Experiment Videos

  • Current management options include observation, biopsy, and prophylactic mastectomy.

    • Conclusions:

    • Further research is needed to establish clear management guidelines for contralateral breast cancer.
    • Breast cancer prevention trials, like those using tamoxifen, may offer future strategies to reduce contralateral risk.